NDC 51662-1220

DOPAMINE HCI

Dopamine Hci

DOPAMINE HCI is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co. Llc, Dba Health First. The primary component is Dopamine Hydrochloride.

Product ID51662-1220_74205252-394a-57fa-e053-2991aa0aee4d
NDC51662-1220
Product TypeHuman Prescription Drug
Proprietary NameDOPAMINE HCI
Generic NameDopamine Hci
Dosage FormInjection, Solution, Concentrate
Route of AdministrationINTRAVENOUS
Marketing Start Date2018-08-23
Marketing CategoryNDA / NDA
Application NumberNDA018132
Labeler NameHF Acquisition Co. LLC, DBA Health First
Substance NameDOPAMINE HYDROCHLORIDE
Active Ingredient Strength40 mg/mL
Pharm ClassesCatecholamine [EPC],Catecholamines [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 51662-1220-1

10 mL in 1 VIAL, SINGLE-DOSE (51662-1220-1)
Marketing Start Date2018-08-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51662-1220-1 [51662122001]

DOPAMINE HCI INJECTION, SOLUTION, CONCENTRATE
Marketing CategoryNDA
Application NumberNDA018132
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-23
Inactivation Date2020-01-31
Reactivation Date2020-02-07

Drug Details

Active Ingredients

IngredientStrength
DOPAMINE HYDROCHLORIDE40 mg/mL

OpenFDA Data

SPL SET ID:74205252-3949-57fa-e053-2991aa0aee4d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1743938
  • Pharmacological Class

    • Catecholamine [EPC]
    • Catecholamines [CS]

    NDC Crossover Matching brand name "DOPAMINE HCI" or generic name "Dopamine Hci"

    NDCBrand NameGeneric Name
    51662-1220DOPAMINE HCIDOPAMINE HCI
    51662-1291DOPAMINE HCIDOPAMINE HCI

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.